Link: Kyoto University Hospital seeks to treat Type 1 diabetes using iPS cells

Kyoto University Hospital aims to pioneer a treatment for severe Type 1 diabetes by using iPS cells reprogrammed into pancreatic islet cells.

This innovative approach could regulate glucose via hormone production, mitigating daily insulin injections for patients.

The hospital plans to initiate a clinical trial by next February, targeting the transplantation of these cells into three individuals.

If successful, this could significantly impact treatment options for the 100,000 to 140,000 people in Japan currently living with this condition.

Researchers anticipate that, pending successful trial outcomes, a transplant treatment could become available in the 2030s.

Ultimately, this development offers hope for a sustainable, long-term solution to managing Type 1 diabetes  #

--

Yoooo, this is a quick note on a link that made me go, WTF? Find all past links here.